Skip to main content

Sigma-Aldrich Discloses $170M Price Tag for Cell Marque Buy

NEW YORK (GenomeWeb) – Sigma-Aldrich said in its Form 10-K recently that it paid about $170 million in cash for Cell Marque, a provider of in vitro diagnostic antibody reagents and kits. 

Sigma-Aldrich acquired Cell Marque in late October but did not disclose the acquisition price at the time. In its document filed with the US Securities Exchange Commission, it estimated the preliminary allocation of the total purchase price consideration at $17 million for net operating assets; $66 million for intangible assets, consisting primarily of customer relationships; and $87 million for goodwill. Sigma-Aldrich added that Cell Marque did not have a material impact on its 2014 earnings. 

Sigma-Aldrich is currently in the process of being acquired by Merck KGaA for $17 billion. The deal is anticipated to be completed by mid-year.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.